½ÃÀ庸°í¼­
»óǰÄÚµå
1813952

³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)

Endoscope Reprocessing And Endoscopic Probe Disinfection Market Size, Share & Trends Analysis Report By Product (High-Level Disinfectants and Test Strips, Detergents and Wipes), By End Use, By Region, And Segment Forecasts, 2025 - 2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå ¿ä¾à

Àü ¼¼°è ³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 21¾ï 9,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2025³âºÎÅÍ 2033³â±îÁö 6.47%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 38¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿À¿°µÈ ³»½Ã°æ°ú °ü·ÃµÈ º´¿ø³» °¨¿°ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÎ ³»½Ã°æ Àçó¸® ¹× ÇÁ·Îºê ¼Òµ¶ ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ Àü ¼¼°èÀûÀ¸·Î ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù.

¾ö°ÝÇÑ ¼¼Ã´ ÇÁ·ÎÅäÄÝ¿¡µµ ºÒ±¸Çϰí Àç»ç¿ë °¡´ÉÇÑ ³»½Ã°æÀº ¿©ÀüÈ÷ ÀÓ»ó ȯ°æ¿¡¼­ ¹Ì»ý¹° ÀüÆÄÀÇ Áß¿äÇÑ ¸Å°³Ã¼ÀÔ´Ï´Ù. 2024³â 3¿ù NCBIÀÇ ¿¬±¸¿¡ µû¸£¸é, Àçó¸®µÈ ³»½Ã°æÀÇ ¿À¿°·üÀº 14.3%¿¡¼­ 47.5%¿¡ ´ÞÇØ Ç¥ÁØ ¼¼Ã´ ¹æ¹ýÀ¸·Î º´¿ø±ÕÀ» Á¦°ÅÇÏ´Â °ÍÀÌ ¿©ÀüÈ÷ ¾î·Á¿î ¹®Á¦¶ó´Â °ÍÀ» ¾Ë ¼ö ÀÖ½À´Ï´Ù.

Àü ¼¼°èÀûÀ¸·Î ¾Ï ¹ßº´·ü°ú »ç¸Á·üÀÇ Áõ°¡´Â ³»½Ã°æ Ä¡·á¸¦ Æ÷ÇÔÇÑ Ã·´Ü Áø´Ü ¹× Ä¡·á ¼ö´Ü¿¡ ´ëÇÑ ¼ö¿ä¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¹Ì±¹¾ÏÇùȸÀÇ Cancer Progress Report 2023¿¡ µû¸£¸é, 2023³â ¹Ì±¹¿¡¼­ ¾à 195¸¸ 8,310¸íÀÌ »õ·Î ¾Ï Áø´ÜÀ» ¹Þ°í 60¸¸ 9,820¸íÀÌ »ç¸ÁÇÒ °ÍÀ¸·Î º¸°íµÇ°í ÀÖ½À´Ï´Ù. 2040³â±îÁö ÀÌ ¼ýÀÚ´Â ¿¬°£ 230¸¸ ¸íÀ¸·Î ´Ã¾î³¯ °ÍÀ¸·Î ¿¹»óµÇ¸ç, Á¶±â¿¡ Á¤È®ÇÑ Áø´Ü µµ±¸ÀÇ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù.

³»½Ã°æÀû ÃÊÀ½ÆÄ°Ë»ç(EUS), ³»½Ã°æ ¿ªÇà Ãé´ã°ü Á¶¿µ¼ú(ERCP) µîÀÇ ³»½Ã°æÀû ½Ã¼úÀº ƯÈ÷ ¼ÒÈ­°ü, ÃéÀå, Æó, ´ã°ü µî ´Ù¾çÇÑ ¾ÏÀÇ ¹ß°ß, º´±âºÐ·ù, °ü¸®¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÃÖ¼Òħ½ÀÀû ½Ã¼úÀº Á¤È®ÇÑ °¡½Ã¼ºÀ» Á¦°øÇϰí, »ý°Ë äÃ븦 ¿ëÀÌÇÏ°Ô Çϸç, Á¾¾ç ÀýÁ¦¼ú°ú °°Àº Ä¡·áÀû °³ÀÔÀ» °¡´ÉÇÏ°Ô ÇÏ´Â µ¿½Ã¿¡ ȯÀÚÀÇ ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­Çϰí, ȸº¹ ½Ã°£À» ´ÜÃàÇϸç, ÇÕº´Áõ À§ÇèÀ» ³·Ãä´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ : ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©

Á¦4Àå ³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå ºÎ¹® ºÐ¼®, Á¦Ç°º°, 2021-2033³â

  • Á¤ÀÇ¿Í ¹üÀ§
  • Á¦Ç° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â ¹× 2033³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå(Á¦Ç°º°, 2021-2033³â)
  • °í¼öÁØ ¼Òµ¶Á¦¡¤½ÃÇèÁö
    • °í¼öÁØ ¼Òµ¶Á¦¡¤½ÃÇèÁö ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
  • ¼¼Á¦¡¤¹°Æ¼½´
    • ¼¼Á¦¡¤¹°Æ¼½´ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
  • ÀÚµ¿ ³»½Ã°æ Àçó¸® Àåºñ(AER)
    • ÀÚµ¿ ³»½Ã°æ Àçó¸® Àåºñ(AER) ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
    • À¯Çü
    • À¯Çü ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
    • È޴뼺
    • È޴뼺 ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
  • ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶
    • ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
    • ³»½Ã°æ ÇÁ·Îºê[ÃÊÀ½ÆÄ(EUS)]
    • ³»½Ã°æ ÇÁ·Îºê[ÃÊÀ½ÆÄ(EUS)]½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
    • Á¦Ç°
    • Á¦Ç° ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
  • ³»½Ã°æ °ÇÁ¶, º¸°ü, ¿î¼Û ½Ã½ºÅÛ
    • ³»½Ã°æ °ÇÁ¶, º¸°ü, ¿î¼Û ½Ã½ºÅÛ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
  • ±âŸ
    • ±âŸ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â

Á¦5Àå ³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå ºÎ¹® ºÐ¼®, ÃÖÁ¾ ¿ëµµº°, 2021-2033³â

  • Á¤ÀÇ¿Í ¹üÀ§
  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â ¹× 2033³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå(ÃÖÁ¾ ¿ëµµº°, 2021-2033³â)
  • º´¿ø
    • º´¿ø ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC)
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC) ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
  • Áø´Ü ½ÇÇè½Ç¡¤¿µ»ó Áø´Ü ¼¾ÅÍ
    • Áø´Ü ½ÇÇè½Ç¡¤¿µ»ó Áø´Ü ¼¾ÅÍ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â
  • ±âŸ
    • ±âŸ ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2021-2033³â

Á¦6Àå ³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå ºÎ¹® ºÐ¼®, Áö¿ªº°, Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, 2021-2033³â

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â ¹× 2033³â
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • Áö¿ª ½ÃÀå ÇöȲ
  • ³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå Á¡À¯À²(Áö¿ªº°, 2024³â ¹× 2033³â)
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ ³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå, 2021-2033³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • À¯·´ÀÇ ³»½Ã°æ Àçó¸® ¹× ³»½Ã°æ ÇÁ·Îºê ¼Òµ¶ ½ÃÀå, 2021-2033³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • ½º¿þµ§
    • µ§¸¶Å©
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦7Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷ÀÇ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷ ºÐ·ù
  • ±â¾÷ °³¿ä
    • STERIS
    • Fortive Corporation(Advanced Sterilization Products)
    • Olympus Corporation
    • Ecolab
    • Getinge AB
    • Steelco SpA
    • ARC Group of Companies Inc.
    • Metrex Research, LLC.
    • Shinva Medical Instrument Co., Ltd.
    • Nanosonics
    • Tristel Plc
    • Germitec
    • CS Medical LLC
    • UV Smart
KSM 25.09.26

Endoscope Reprocessing And Endoscopic Probe Disinfection Market Summary

The global endoscope reprocessing and endoscopic probe disinfection market size was estimated at USD 2.19 billion in 2024 and is projected to reach USD 3.81 billion by 2030, growing at a CAGR of 6.47% from 2025 to 2033. The increasing incidence of nosocomial infections associated with contaminated endoscopes has brought global attention to the critical need for effective endoscope reprocessing and probe disinfection solutions.

Despite strict cleaning protocols, reusable endoscopes remain a significant vector for microbial transmission in clinical settings. According to a study by the NCBI in March 2024, contamination rates in reprocessed endoscopes ranged from 14.3% to 47.5%, highlighting the persistent challenge of eliminating pathogens through standard cleaning methods.

The increasing global burden of cancer and related mortality is significantly influencing the demand for advanced diagnostic and treatment modalities, including endoscopic procedures. According to the Cancer Progress Report 2023 by the American Cancer Society, approximately 1,958,310 new cancer cases were diagnosed in the U.S. in 2023, with 609,820 deaths reported. By 2040, this number will rise to 2.3 million new cases annually, highlighting the need for early and accurate diagnostic tools.

Endoscopic procedures such as Endoscopic Ultrasonography (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) are critical in the detection, staging, and management of various cancers, especially in the gastrointestinal tract, pancreas, lungs, and bile ducts. These minimally invasive techniques offer precise visualization, facilitate biopsy collection, and allow therapeutic interventions such as tumor resection, all while minimizing patient discomfort, reducing recovery time, and lowering the risk of complications.

Global Endoscope Reprocessing and Endoscopic Probe Disinfection Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global endoscope reprocessing and endoscopic probe disinfection market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • High-Level Disinfectants and Test Strips
  • Detergents and Wipes
  • Automated Endoscope Reprocessors
    • By Type
    • Single Basin
    • Double Basin
    • By Portability
    • Standalone
    • Portable
  • Endoscopic Probe Disinfection
    • Endoscopic Probes [Ultrasound (EUS)]
    • Convex Probes
    • Linear Probes
    • Transesophageal (TEE) Probes
    • Endoscopic Probes [Ultrasound (EUS)]
    • Instruments
    • Consumables
  • Endoscope Drying, Storage, and Transport Systems
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Diagnostic Laboratories and Imaging Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • Spain
    • Italy
    • France
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Endoscope Reprocessing and Endoscopic Probe Disinfection Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of noscomial infection
      • 3.2.1.2. Increasing prevalence of cancer and cancer-related mortality worldwide
      • 3.2.1.3. Increase in the number of healthcare centers and strategic alliances in endoscopy
      • 3.2.1.4. Rising number of product launches
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Rising shift towards disposable endoscopes
      • 3.2.2.2. Product recalls
  • 3.3. Endoscope Reprocessing and Endoscopic Probe Disinfection: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Framework

Chapter 4. Endoscope Reprocessing and Endoscopic Probe Disinfection Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Endoscope Reprocessing and Endoscopic Probe Disinfection Market, by product, 2021 to 2033
  • 4.5. High-Level Disinfectants and Test Strips
    • 4.5.1. High-level disinfectants and test strips market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Detergents and wipes
    • 4.6.1. Detergents and wipes market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Automated Endoscope Reprocessors (AERs)
    • 4.7.1. Automated endoscope reprocessors (AERs) market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.2. Type
    • 4.7.3. Type market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.3.1. Single basin
        • 4.7.3.1.1. Single basin market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.3.2. Double basin
        • 4.7.3.2.1. Double basin market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.4. Portability
    • 4.7.5. Portability market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.5.1. Standalone
        • 4.7.5.1.1. Standalone market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.5.2. Portable
        • 4.7.5.2.1. Portable market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8. Endoscopic Probe Disinfection
    • 4.8.1. Endoscopic probe disinfection market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.8.2. Endoscopic Probes [Ultrasound (EUS)]
    • 4.8.3. Endoscopic Probes [Ultrasound (EUS)] market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.8.3.1. Convex Probes
        • 4.8.3.1.1. Convex probes market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.8.3.2. Linear Probes
        • 4.8.3.2.1. Linear probes market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.8.3.3. Transesophageal (TEE) Probes
        • 4.8.3.3.1. Transesophageal (TEE) probes market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.8.4. Products
    • 4.8.5. Products market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.8.5.1. Instruments
        • 4.8.5.1.1. Instruments market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.8.5.2. Consumables
        • 4.8.5.2.1. Consumables market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.9. Endoscope Drying, Storage, and Transport Systems
    • 4.9.1. Endoscope drying, storage, and transport systems market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.10. Others
    • 4.10.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Endoscope Reprocessing and Endoscopic Probe Disinfection Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Endoscope Reprocessing and Endoscopic Probe Disinfection Market, by End Use, 2021 to 2033
  • 5.5. Hospitals
    • 5.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD million)
  • 5.6. Ambulatory Surgical Centers (ASCs)
    • 5.6.1. Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Diagnostic Laboratories and Imaging Centers
    • 5.7.1. Diagnostic laboratories and imaging centers market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Endoscope Reprocessing and Endoscopic Probe Disinfection Market Segment Analysis, By Region, By Product, By End Use, 2021 - 2033 (USD Million)

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Endoscope Reprocessing and Endoscopic Probe Disinfection Market Share by Region, 2024 & 2033:
  • 6.5. North America
    • 6.5.1. North America endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. U.S. endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Canada endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Mexico endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. UK endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Germany endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. France endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Italy endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Spain endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Norway endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Sweden endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Denmark endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Japan endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. China endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. India endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Australia endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. South Korea endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Thailand endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Brazil endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Argentina endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. South Africa endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Saudi Arabia endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. UAE endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Kuwait endoscope reprocessing and endoscopic probe disinfection market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
    • 7.3.1. STERIS
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Fortive Corporation (Advanced Sterilization Products)
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Olympus Corporation
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Ecolab
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Getinge AB
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Steelco S.p.A
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. ARC Group of Companies Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Metrex Research, LLC.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Shinva Medical Instrument Co., Ltd.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Nanosonics
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Tristel Plc
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Germitec
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. CS Medical LLC
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. UV Smart
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦